These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

666 related items for PubMed ID: 29487003

  • 1. SATB2 is a supportive marker for the differentiation of a primary mucinous tumor of the ovary and an ovarian metastasis of a low-grade appendiceal mucinous neoplasm (LAMN): A series of seven cases.
    Schmoeckel E, Kirchner T, Mayr D.
    Pathol Res Pract; 2018 Mar; 214(3):426-430. PubMed ID: 29487003
    [Abstract] [Full Text] [Related]

  • 2. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.
    Moh M, Krings G, Ates D, Aysal A, Kim GE, Rabban JT.
    Am J Surg Pathol; 2016 Mar; 40(3):419-32. PubMed ID: 26551622
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemical characterization of appendiceal mucinous neoplasms and the value of special AT-rich sequence-binding protein 2 in their distinction from primary ovarian mucinous tumours.
    Strickland S, Parra-Herran C.
    Histopathology; 2016 Jun; 68(7):977-87. PubMed ID: 26542609
    [Abstract] [Full Text] [Related]

  • 4. The utility of PAX8 and SATB2 immunohistochemical stains in distinguishing ovarian mucinous neoplasms from colonic and appendiceal mucinous neoplasm.
    Aldaoud N, Erashdi M, AlKhatib S, Abdo N, Al-Mohtaseb A, Graboski-Bauer A.
    BMC Res Notes; 2019 Nov 26; 12(1):770. PubMed ID: 31771640
    [Abstract] [Full Text] [Related]

  • 5. A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.
    Meagher NS, Wang L, Rambau PF, Intermaggio MP, Huntsman DG, Wilkens LR, El-Bahrawy MA, Ness RB, Odunsi K, Steed H, Herpel E, Anglesio MS, Zhang B, Lambie N, Swerdlow AJ, Lubiński J, Vierkant RA, Goode EL, Menon U, Toloczko-Grabarek A, Oszurek O, Bilic S, Talhouk A, García-Closas M, Wang Q, Tan A, Farrell R, Kennedy CJ, Jimenez-Linan M, Sundfeldt K, Etter JL, Menkiszak J, Goodman MT, Klonowski P, Leung Y, Winham SJ, Moysich KB, Behrens S, Kluz T, Edwards RP, Gronwald J, Modugno F, Hernandez BY, Chow C, Kelemen LE, Keeney GL, Carney ME, Natanzon Y, Robertson G, Sharma R, Gayther SA, Alsop J, Luk H, Karpinskyj C, Campbell I, Sinn P, Gentry-Maharaj A, Coulson P, Chang-Claude J, Shah M, Widschwendter M, Tang K, Schoemaker MJ, Koziak JM, Cook LS, Brenton JD, Daley F, Kristjansdottir B, Mateoiu C, Larson MC, Harnett PR, Jung A, deFazio A, Gorringe KL, Pharoah PDP, Minoo P, Stewart C, Bathe OF, Gui X, Cohen P, Ramus SJ, Köbel M.
    Mod Pathol; 2019 Dec 26; 32(12):1834-1846. PubMed ID: 31239549
    [Abstract] [Full Text] [Related]

  • 6. The value of SATB2 in the differential diagnosis of intestinal-type mucinous tumors of the ovary: primary vs metastatic.
    Perez Montiel D, Arispe Angulo K, Cantú-de León D, Bornstein Quevedo L, Chanona Vilchis J, Herrera Montalvo L.
    Ann Diagn Pathol; 2015 Aug 26; 19(4):249-52. PubMed ID: 26059401
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemistry in the Diagnosis of Mucinous Neoplasms Involving the Ovary: The Added Value of SATB2 and Biomarker Discovery Through Protein Expression Database Mining.
    Strickland S, Wasserman JK, Giassi A, Djordjevic B, Parra-Herran C.
    Int J Gynecol Pathol; 2016 May 26; 35(3):191-208. PubMed ID: 26535987
    [Abstract] [Full Text] [Related]

  • 8. [Clinicopathologic characteristics and histogenesis of mucinous tumor of peritoneum].
    Zhang H, Sun Y, Huang X, Jia L, Bai Y, Cao D.
    Zhonghua Bing Li Xue Za Zhi; 2014 Mar 26; 43(3):163-8. PubMed ID: 24842014
    [Abstract] [Full Text] [Related]

  • 9. KRAS and GNAS Co-Mutation in Metastatic Low-Grade Appendiceal Mucinous Neoplasm (LAMN) to the Ovaries: A Practical Role for Next-Generation Sequencing.
    Matson DR, Xu J, Huffman L, Barroilhet L, Accola M, Rehrauer WM, Weisman P.
    Am J Case Rep; 2017 May 20; 18():558-562. PubMed ID: 28526814
    [Abstract] [Full Text] [Related]

  • 10. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary.
    Vang R, Gown AM, Zhao C, Barry TS, Isacson C, Richardson MS, Ronnett BM.
    Am J Surg Pathol; 2007 Jun 20; 31(6):854-69. PubMed ID: 17527072
    [Abstract] [Full Text] [Related]

  • 11. Appendiceal mucinous neoplasm mimics ovarian tumors: Challenges for preoperative and intraoperative diagnosis and clinical implication.
    Zhang W, Tan C, Xu M, Wu X.
    Eur J Surg Oncol; 2019 Nov 20; 45(11):2120-2125. PubMed ID: 31462390
    [Abstract] [Full Text] [Related]

  • 12. Dual Immunostain With SATB2 and CK20 Differentiates Appendiceal Mucinous Neoplasms From Ovarian Mucinous Neoplasms.
    Li Z, Roth R, Rock JB, Lehman A, Marsh WL, Suarez A, Frankel WL.
    Am J Clin Pathol; 2017 May 01; 147(5):484-491. PubMed ID: 28340228
    [Abstract] [Full Text] [Related]

  • 13. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
    McKenney JK, Soslow RA, Longacre TA.
    Am J Surg Pathol; 2008 May 01; 32(5):645-55. PubMed ID: 18344868
    [Abstract] [Full Text] [Related]

  • 14. Mucinous tumors of the vermiform appendix and ovary, and pseudomyxoma peritonei: histogenetic implications of cytokeratin 7 expression.
    Guerrieri C, Frånlund B, Fristedt S, Gillooley JF, Boeryd B.
    Hum Pathol; 1997 Sep 01; 28(9):1039-45. PubMed ID: 9308728
    [Abstract] [Full Text] [Related]

  • 15. Ovarian mucinous tumour arising in mature cystic teratoma and associated with pseudomyxoma peritonei: report of two cases and comparison with ovarian involvement by low-grade appendiceal mucinous tumour.
    Stewart CJ, Tsukamoto T, Cooke B, Leung YC, Hammond IG.
    Pathology; 2006 Dec 01; 38(6):534-8. PubMed ID: 17393980
    [Abstract] [Full Text] [Related]

  • 16. An evaluation of the morphologic features of low-grade mucinous neoplasms of the appendix metastatic in the ovary, and comparison with primary ovarian mucinous tumors.
    Stewart CJ, Ardakani NM, Doherty DA, Young RH.
    Int J Gynecol Pathol; 2014 Jan 01; 33(1):1-10. PubMed ID: 24300528
    [Abstract] [Full Text] [Related]

  • 17. Pseudomyxoma peritonei and selected other aspects of the spread of appendiceal neoplasms.
    Young RH.
    Semin Diagn Pathol; 2004 May 01; 21(2):134-50. PubMed ID: 15807473
    [Abstract] [Full Text] [Related]

  • 18. Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential.
    Ronnett BM, Kurman RJ, Zahn CM, Shmookler BM, Jablonski KA, Kass ME, Sugarbaker PH.
    Hum Pathol; 1995 May 01; 26(5):509-24. PubMed ID: 7750935
    [Abstract] [Full Text] [Related]

  • 19. Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas.
    Ji H, Isacson C, Seidman JD, Kurman RJ, Ronnett BM.
    Int J Gynecol Pathol; 2002 Oct 01; 21(4):391-400. PubMed ID: 12352188
    [Abstract] [Full Text] [Related]

  • 20. Significance of SATB2 expression in colon cancer and its differential diagnosis in digestive tract adenocarcinoma and ovarian primary and metastatic carcinoma.
    Liu F, Gao Z, Shen D, Zhao H, Wang C, Ye Y, Ma Y, Kong F.
    Pathol Res Pract; 2019 Jul 01; 215(7):152430. PubMed ID: 31101576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.